Insmed Martina Flammer proposes $1.35M share sale

Five earlier common-stock sales are listed from May 11 through June 5, 2026, with a Rule 10b5-1 plan adoption or instruction date of February 27, 2025.

Accepted by SEC EDGAR 07/06/2026 - 04:20 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

INSMED Inc. officer Martina Flammer reported a proposed sale of 12,302 common shares, with an aggregate market value of $1,352,864, through Merrill Lynch, at an approximate sale date of July 6, 2026. The shares were acquired from the issuer through stock plan activity on July 6, 2026. A Rule 10b5-1 plan adoption or instruction date of February 27, 2025 is listed. Five earlier common-stock sales are reported from May 11 through June 5, 2026.

Key Figures

Shares to be sold: 12,302 shares Aggregate market value: $1,352,864 Approximate sale date: July 6, 2026 +4 more

7 metrics

Shares to be sold 12,302 shares Proposed sale

Aggregate market value $1,352,864 Proposed sale

Approximate sale date July 6, 2026 Proposed sale

Shares outstanding 216,752,451 shares INSMED common shares

Earlier sale 1,858 shares; gross proceeds $192,811 June 5, 2026

Earlier sale 2,566 shares; gross proceeds $262,418 June 3, 2026

Plan adoption or instruction date February 27, 2025 Rule 10b5-1

Key Terms

Rule 10b5-1, Aggregate Market Value, Gross Proceeds, Stock Plan Activity

4 terms

Rule 10b5-1 regulatory

"If Relying on Rule 10b5-1"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Gross Proceeds financial

"Gross Proceeds"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

Stock Plan Activity financial

"Nature of Acquisition Transaction: Stock Plan Activity"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares is INSM officer Martina Flammer proposing to sell?

Martina Flammer reported a proposed sale of 12,302 common shares, with an aggregate market value of $1,352,864. The approximate sale date is July 6, 2026, and Merrill Lynch is named as broker.

What prior stock sales did INSM officer Martina Flammer report?

The reported sales were 12,949 shares for gross proceeds of $1,300,105 on May 11, 2026; 7,854 shares for $897,137 on May 13; 10,479 shares for $1,231,599 on May 14; 2,566 shares for $262,418 on June 3; and 1,858 shares for $192,811 on June 5.

When was the Rule 10b5-1 plan adopted for INSM officer Martina Flammer?

The listed date for adoption of the Rule 10b5-1 plan or giving an instruction is February 27, 2025.

How did Martina Flammer acquire the INSM shares proposed for sale?

The 12,302 shares were acquired from the issuer through stock plan activity on July 6, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001796960
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	INSMED INC
SEC File Number	000-30739
Address of Issuer	700 US Highway 202/206 Bridgewater NEW JERSEY 08807
Phone	9089779900
Name of Person for Whose Account the Securities are To Be Sold	Martina Flammer
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 1800 K ST NW Suite 800 Washington DC 20006	12302	1352864	216752451	07/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/06/2026	Stock Plan Activity	Issuer			12302	07/06/2026	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Martina Flammer 700 US Highway 202/206 Bridgewater NJ 08807	Common	06/05/2026	1858	192811
Martina Flammer 700 US Highway 202/206 Bridgewater NJ 08807	Common	06/03/2026	2566	262418
Martina Flammer 700 US Highway 202/206 Bridgewater NJ 08807	Common	05/14/2026	10479	1231599
Martina Flammer 700 US Highway 202/206 Bridgewater NJ 08807	Common	05/13/2026	7854	897137
Martina Flammer 700 US Highway 202/206 Bridgewater NJ 08807	Common	05/11/2026	12949	1300105

144: Remarks and Signature

Remarks
Date of Notice	07/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/27/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Martina Flammer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)